jc
@JadChahoud
Followers
663
Following
8K
Statuses
2K
Genitourinary Medical Oncologist @MoffittNews @MoffittResearch
Joined April 2012
RT @PatrickHwuMD: Something exciting is in the works and it’s going to be out of this world!🪐🎙️ We’re launching a podcast soon, and can’t w…
0
7
0
RT @ConquerCancerFd: We are pleased to announce the recipients of 2025 Genitourinary Cancers Symposium Merit Awards to recognize first auth…
0
7
0
RT @Larvol: Shining the spotlight on the top oncologists driving breakthroughs in cancer care. We are celebrating your dedication, which fu…
0
12
0
RT @ryanhuey: Early onset colorectal is on the rise, and patients have unique needs. @vserpashigbie and I co-wrote a piece on this in #ASCO…
0
11
0
@neerajaiims @Huntsman_GU @ASCO @ConquerCancerFd @ziremozay @nsayeghmd @urotoday @PCFnews @OncoAlert @montypal @DrChoueiri @PGrivasMDPhD @shilpaonc @TiansterZhang @umangtalking @DrYukselUrun @AzadOncology @ASCOPres @PBarataMD Congrats! Super star teama and mentor ⭐️⭐️
0
0
8
RT @AndreaNecchi: Something you have to secure in your agenda! @SanRaffaeleMI @MyUniSR @UroDocAsh @montypal @SpiessPhilippe @neerajaiims @P…
0
8
0
🚨 A comprehensive review on Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas lead by super 🌟 @JMillerMed @MoffittResearch 🌟
1
7
18
RT @JenniferLitton: Great case discussions from our GU team reviewing adjuvant pembro this morning. And remembering Chris Wood. @MDAnders…
0
5
0
RT @mjmoussa_: 🔥 OUR LATEST #OriginalResearch in @CancerMedicineJ on Small Cell Neuroendocrine Carcinoma of the Urinary Tract (SCNEC-URO)👉W…
0
25
0
RT @OncJournal: Tivozanib in heavily pretreated pts w/ clear cell RCC: retrospective analysis @mdandersonnews showed ORR 7.7%, PFS 3.8mos,…
0
10
0
RT @AndreaNecchi: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Resul…
0
20
0
RT @RyanNipp: Financial Toxicity in #Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. https://t.co/…
0
22
0
RT @montypal: One of the reason I love serving as an AE for @CACancerJournal is the opportunity to review/learn from terrific pieces like t…
0
10
0
RT @ggebraelmd: Excited to see this piece published @CACancerJournal about PARPi indications across all #cancers ➡️
0
4
0
@PavlosMsaouel @CellPressNews @MDAndersonNews @MoffittNews @KidneyCancer @kidneycan Same here my friend always missing my GU @MDAndersonNews family 👑 onwards for a bigger impact collaborating together! ⭐️
0
0
2
@PavlosMsaouel @NatureComms @PGrivasMDPhD @montypal @VivekSubbiah @IamLinghua @KidneyCancer @kidneycan @kcCURE @neerajaiims @rahulshethmd Congratulations my ⭐️👑 friend on this impactful work!!
1
0
2
RT @PavlosMsaouel: 1/5 Thrilled to share in @NatureComms the clinical outcomes and scRNA-seq correlatives our phase I triplet immunotherapy…
0
47
0